These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

705 related articles for article (PubMed ID: 34105297)

  • 1. Physiological and Pathological Factors Affecting Drug Delivery to the Brain by Nanoparticles.
    Islam Y; Leach AG; Smith J; Pluchino S; Coxon CR; Sivakumaran M; Downing J; Fatokun AA; Teixidò M; Ehtezazi T
    Adv Sci (Weinh); 2021 Jun; 8(11):e2002085. PubMed ID: 34105297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain Targeting Nanomedicines: Pitfalls and Promise.
    Kakinen A; Jiang Y; Davis TP; Teesalu T; Saarma M
    Int J Nanomedicine; 2024; 19():4857-4875. PubMed ID: 38828195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Central nervous system delivery of molecules across the blood-brain barrier.
    Gosselet F; Loiola RA; Roig A; Rosell A; Culot M
    Neurochem Int; 2021 Mar; 144():104952. PubMed ID: 33400964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Active Targeting Towards and Inside the Brain based on Nanoparticles: A Review.
    Rabiei M; Kashanian S; Samavati SS; Jamasb S; McInnes SJP
    Curr Pharm Biotechnol; 2020; 21(5):374-383. PubMed ID: 31793421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multifunctional Nanocarriers for diagnostics, drug delivery and targeted treatment across blood-brain barrier: perspectives on tracking and neuroimaging.
    Bhaskar S; Tian F; Stoeger T; Kreyling W; de la Fuente JM; Grazú V; Borm P; Estrada G; Ntziachristos V; Razansky D
    Part Fibre Toxicol; 2010 Mar; 7():3. PubMed ID: 20199661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting receptor-ligand chemistry for drug delivery across blood-brain barrier in brain diseases.
    Anthony DP; Hegde M; Shetty SS; Rafic T; Mutalik S; Rao BSS
    Life Sci; 2021 Jun; 274():119326. PubMed ID: 33711385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigating the optimum size of nanoparticles for their delivery into the brain assisted by focused ultrasound-induced blood-brain barrier opening.
    Ohta S; Kikuchi E; Ishijima A; Azuma T; Sakuma I; Ito T
    Sci Rep; 2020 Oct; 10(1):18220. PubMed ID: 33106562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Getting into the brain: approaches to enhance brain drug delivery.
    Patel MM; Goyal BR; Bhadada SV; Bhatt JS; Amin AF
    CNS Drugs; 2009; 23(1):35-58. PubMed ID: 19062774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of Polymeric Nanoparticles for Blood-Brain Barrier Transfer-Strategies and Challenges.
    Zhang W; Mehta A; Tong Z; Esser L; Voelcker NH
    Adv Sci (Weinh); 2021 May; 8(10):2003937. PubMed ID: 34026447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Size, surface charge, and shape determine therapeutic effects of nanoparticles on brain and retinal diseases.
    Jo DH; Kim JH; Lee TG; Kim JH
    Nanomedicine; 2015 Oct; 11(7):1603-11. PubMed ID: 25989200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The potential for nanoparticle-based drug delivery to the brain: overcoming the blood-brain barrier.
    Barbu E; Molnàr E; Tsibouklis J; Górecki DC
    Expert Opin Drug Deliv; 2009 Jun; 6(6):553-65. PubMed ID: 19435406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The ability of liposomes, tailored for blood-brain barrier targeting, to reach the brain is dramatically affected by the disease state.
    Magro RD; Cox A; Zambelli V; Mancini S; Masserini M; Re F
    Nanomedicine (Lond); 2018 Mar; 13(6):585-594. PubMed ID: 29376461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanoparticles for Targeted Brain Drug Delivery: What Do We Know?
    Pinheiro RGR; Coutinho AJ; Pinheiro M; Neves AR
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The blood-brain barrier and beyond: Nano-based neuropharmacology and the role of extracellular matrix.
    Henrich-Noack P; Nikitovic D; Neagu M; Docea AO; Engin AB; Gelperina S; Shtilman M; Mitsias P; Tzanakakis G; Gozes I; Tsatsakis A
    Nanomedicine; 2019 Apr; 17():359-379. PubMed ID: 30759369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sialic acid (SA)-modified selenium nanoparticles coated with a high blood-brain barrier permeability peptide-B6 peptide for potential use in Alzheimer's disease.
    Yin T; Yang L; Liu Y; Zhou X; Sun J; Liu J
    Acta Biomater; 2015 Oct; 25():172-83. PubMed ID: 26143603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Small Scale, Big Impact: Nanotechnology-Enhanced Drug Delivery for Brain Diseases.
    Miao K; Xia X; Zou Y; Shi B
    Mol Pharm; 2024 Aug; 21(8):3777-3799. PubMed ID: 39038108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent advances on drug delivery nanocarriers for cerebral disorders.
    Zhou Z; Sun T; Jiang C
    Biomed Mater; 2021 Feb; 16(2):024104. PubMed ID: 33455956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug targeting to brain: a systematic approach to study the factors, parameters and approaches for prediction of permeability of drugs across BBB.
    Nagpal K; Singh SK; Mishra DN
    Expert Opin Drug Deliv; 2013 Jul; 10(7):927-55. PubMed ID: 23330786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent expansions of novel strategies towards the drug targeting into the brain.
    Alexander A; Agrawal M; Uddin A; Siddique S; Shehata AM; Shaker MA; Ata Ur Rahman S; Abdul MIM; Shaker MA
    Int J Nanomedicine; 2019; 14():5895-5909. PubMed ID: 31440051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting the central nervous system: From synthetic nanoparticles to extracellular vesicles-Focus on Alzheimer's and Parkinson's disease.
    Hernando S; Santos-Vizcaíno E; Igartua M; Hernandez RM
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2023; 15(5):e1898. PubMed ID: 37157144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.